Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 4/2009

01-04-2009 | Case Reports

Retroperitoneal tumour radiotherapy: clinical improvements using kilovoltage cone beam computed tomography

Authors: Xavier J. Juan-Senabre, Carlos Ferrer-Albiach, Marta Rodríguez-Cordón, Agustín Santos-Serra, Juan López-Tarjuelo, Salvador Calzada-Feliu

Published in: Clinical and Translational Oncology | Issue 4/2009

Login to get access
Metadata
Title
Retroperitoneal tumour radiotherapy: clinical improvements using kilovoltage cone beam computed tomography
Authors
Xavier J. Juan-Senabre
Carlos Ferrer-Albiach
Marta Rodríguez-Cordón
Agustín Santos-Serra
Juan López-Tarjuelo
Salvador Calzada-Feliu
Publication date
01-04-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 4/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-009-0349-3

Other articles of this Issue 4/2009

Clinical and Translational Oncology 4/2009 Go to the issue

Educational Series

Genetic alterations in chronic lymphocytic leukaemia

Case Reports

Peritoneal solitary fibrous tumour (SFT): long-term survival of recurrent and metastasised SFT treated with cytoreductive surgery and intraperitoneal chemotherapy

Research Articles

Chemopreventive efficacies of rosiglitazone, fenretinide and their combination against rat mammary carcinogenesis

Research Articles

Screening practice and misplaced priorities

Editorial

Continuing medical education (CME) or continuing professional development (CPD): a need, a challenge, but also a must

Educational Series

Hedgehog signalling as a target in cancer stem cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits